IL6 and COVID-19: It has been postulated that IL-6 plays a critical role in virus-induced cytokine storm, hence, a recombinant humanized monoclonal antibody IL-6 receptor inhibitor, tocilizumab, has recently emerged as an alternative treatment for COVID-19 [51].